8th International Workshop on HIV Paediatrics, 15-16 July 2016, Durban, South Africa
The slides of the presentations given during the meeting and the webcasts of these presentations, are published online when consent has been provided.
Reports in this issue of HTB are:
- No increased resistance with once daily dosing of abacavir and
3TC than twice daily dosing in the ARROW trial
- Raltegravir in HIV-exposed neonates
- Virological response without routine viral load monitoring in children: results from the ARROW trial
- Tenofovir-containing ART reduces bone mineral density in breast feeding women: results from IMPAACT P1084s